Comprehensive characterization of FGF/FGFR alterations in invasive breast cancers

被引:0
|
作者
Gaur, Kush C. [1 ]
Tiu-Lim, Justin [2 ]
McGrath, Julie [3 ]
Walker, Phil [3 ]
Korn, Michael [3 ]
Xiu, Joanne [3 ]
Heeke, Arielle [4 ]
Kaklamani, Virginia [5 ]
Tan, Antoinette [4 ]
Lu, Janice [2 ]
Spicer, Darcy [2 ]
Roussos-Torres, Evanthia [2 ]
Jayachandran, Priya [2 ]
Saghian, Audrey [2 ]
Goldkorn, Amir [2 ]
Kang, Irene [2 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[2] USC Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
[5] UT Hlth San Antonio, MD Anderson Canc Ctr, San Antonio, TX USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5793
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers
    Qing Wang
    Keltouma Driouch
    Stéphanie Courtois
    Marie Hélène Champème
    Ivan Bièche
    Isabelle Treilleux
    Marianne Briffod
    Ruth Rimokh
    Jean Pierre Magaud
    Patrick Curmi
    Rosette Lidereau
    Alain Puisieux
    Oncogene, 1998, 16 : 677 - 679
  • [42] Prevalence and spectrum of microsatellite alterations in nonmuscle invasive bladder cancers
    Legrand, Guillaume
    Soliman, Hany
    Dubosq, Francis
    Verine, Jerome
    Desgrandchamps, Francois
    de The, Hugues
    Mongiat-Artus, Pierre
    Ploussard, Guillaume
    AMERICAN JOURNAL OF CANCER RESEARCH, 2011, 1 (05): : 595 - 603
  • [43] Alterations of the retinoblastoma gene in stage Ill breast cancers
    Berge, Elisabet O.
    Knappskog, Stian
    Geisler, Stephanie
    Staalesen, Vidar
    Puntervoll, Pal
    Pacal, Marek
    Borresen-Dale, Anne-Lise
    Lillehaug, Johan R.
    Lonning, Per E.
    CANCER RESEARCH, 2010, 70
  • [44] Comprehensive Molecular and Immunological Characterization of Invasive Ductal Triple-Negative Breast Cancer
    Advani, Pooja
    Deshmukh, Sachin
    Wu, Sharon
    Andring, Jacob
    Xiu, Joanne
    Farrell, Alex
    Leone, Jose
    Jayachandran, Priya
    Graff, Stephanie
    Oberley, Matthew
    Sledge, George, Jr.
    Chanan-Khan, Asher
    CANCER RESEARCH, 2024, 84 (09)
  • [45] Efficacy of futibatinib, an irreversible fibroblast growth factor receptor (FGFR) inhibitor, in breast cancer models with FGFR alterations
    Saridogan, Turcin
    Akcakanat, Argun
    Zhao, Ming
    Evans, Kurt W.
    Yuca, Erkan
    Scott, Stephen
    Kirby, Bryce P.
    Zheng, Xiaofeng
    Damodaran, Senthil
    Meric-Bernstam, Funda
    CANCER RESEARCH, 2022, 82 (04)
  • [46] FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
    Furugaki, Koh
    Fujimura, Takaaki
    Mizuta, Hayato
    Yoshimoto, Takuya
    Asakawa, Takashi
    Yoshimura, Yasushi
    Yoshiura, Shigeki
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [47] FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes
    Koh Furugaki
    Takaaki Fujimura
    Hayato Mizuta
    Takuya Yoshimoto
    Takashi Asakawa
    Yasushi Yoshimura
    Shigeki Yoshiura
    npj Precision Oncology, 7
  • [48] Comprehensive characterization of clock genes in human cancers
    Ye, Youqiong
    Xiang, Yu
    Takahashi, Joseph
    Mills, Gordon
    Yoo, Seung-Hee
    Han, Leng
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites
    Cha, Soojin
    Lee, Esak
    Won, Hong-Hee
    NPJ BREAST CANCER, 2021, 7 (01)
  • [50] Comprehensive identification and characterization of somatic copy number alterations in triple-negative breast cancer
    Li, Zaibing
    Zhang, Xiao
    Hou, Chenxin
    Zho, Yuqing u
    Chen, Junli
    Cai, Haoyang
    Ye, Yifeng
    Liu, Jinping
    Huang, Ning
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (02) : 522 - 530